The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Multiple receptors for dopamine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Psychopharmacology : a generation of progress
Lipton, M. A., DiMascio, A., & Killam, K. F. (1978) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,212
Kebabian, J. W., Petzold, G. L., & Greengard, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.8.2145 · Cited by 1,022
Self-citationPsychopharmacology: A Generation of Progress
Ananth, J. (1979) · Psychosomatics · doi:10.1016/s0033-3182(79)73729-7 · Cited by 844
PRE AND POSTSYNAPTIC RECEPTORS
Rees, D. (1976) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.10.1035 · Cited by 775
The central effects of a novel dopamine agonist
Setler, P. E., Sarau, H. M., Zirkle, C. L., & Saunders, H. L. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90148-6 · Cited by 639
Aghajanian, G. K., & Bunney, B. S. (1977) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00508803 · Cited by 547
Iversen, L. L. (1975) · Science · doi:10.1126/science.2976 · Cited by 527
Studies on the Mechanism of the Dopamine-Mediated Inhibition of Prolactin Secretion1
MACLEOD, R. M., & LEHMEYER, J. E. (1974) · Endocrinology · doi:10.1210/endo-94-4-1077 · Cited by 495
Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L., & Greengard, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1113 · Cited by 452
Self-citation
Cited by
Items 101–168 of 168
Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor
Tsuruta, K., Frey, E. A., Grewe, C. W., Cote, T. E., Eskay, R. L., & Kebabian, J. W. (1981) · Nature · doi:10.1038/292463a0 · Cited by 343
Self-citationAltered striatal function in a mutant mouse lacking D1A dopamine receptors.
Drago, J., Gerfen, C. R., Lachowicz, J. E., Steiner, H., Hollon, T. R., Love, P. E., Ooi, G. T., Grinberg, A., Lee, E. J., & Huang, S. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12564 · Cited by 343
Jones, G. H., Hernandez, T. D., Kendall, D. A., Marsden, C. A., & Robbins, T. W. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90635-s · Cited by 341
D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis
Dawson, T., Gehlert, D., McCabe, R., Barnett, A., & Wamsley, J. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02352.1986 · Cited by 342
Molecular effects of dopamine on striatal-projection pathways
Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 341
De Souza, E. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-01-00088.1987 · Cited by 338
Dopamine, a neurotransmitter, influences the immune system
Basu, S., & Dasgupta, P. S. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00176-9 · Cited by 335
Interleukin‐8 as a mediator of sympathetic pain
Cunha, F. Q., Lorenzetti, B. B., Poole, S., & Ferreira, S. H. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12502.x · Cited by 333
Xu, M., Hu, X.-T., Cooper, D. C., Moratalla, R., Graybiel, A. M., White, F. J., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90026-4 · Cited by 331
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
Farde, L., Wiesel, F. A., Nordstr�m, A. L., & Sedvall, G. (1989) · Psychopharmacology · doi:10.1007/bf00442555 · Cited by 325
Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors
Braun, A. R., & Chase, T. N. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90588-1 · Cited by 321
Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390
Savasta, M., Dubois, A., & Scatton, B. (1986) · Brain Research · doi:10.1016/0006-8993(86)90749-3 · Cited by 318
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Mailman, R., & Murthy, V. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361461 · Cited by 311
Prolactin Levels and Adverse Events in Patients Treated with Risperidone
Kleinberg, D. L., Davis, J. M., de Coster, R., Van Baelen, B., & Brecher, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00011 · Cited by 307
What Keeps Us Awake: the Neuropharmacology of Stimulants and Wakefulness Promoting Medications
Boutrel, B., & Koob, G. F. (2004) · Sleep · doi:10.1093/sleep/27.6.1181 · Cited by 307
Dopamine receptors in human brain: Autoradiographic distribution of D2 sites
Camps, M., Cortés, R., Gueye, B., Probst, A., & Palacios, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90179-6 · Cited by 305
Targeting the dopamine D2receptor in schizophrenia
Seeman, P. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.515 · Cited by 302
Farde, L., Ehrin, E., Eriksson, L., Greitz, T., Hall, H., Hedström, C. G., Litton, J. E., & Sedvall, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3863 · Cited by 300
Paul, M., Graybiel, A., David, J., & Robertson, H. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-03729.1992 · Cited by 299
de la Mora, M. P., Gallegos-Cari, A., Arizmendi-García, Y., Marcellino, D., & Fuxe, K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.010 · Cited by 296
Bodis-Wollner, I. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90113-o · Cited by 296
Sibley, D. R., De Lean, A., & Creese, I. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)65148-1 · Cited by 293
Matt, S. M., & Gaskill, P. J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09851-4 · Cited by 287
Neurobehavioral evidence for changes in dopamine system activity during adolescence
Wahlstrom, D., White, T., & Luciana, M. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.007 · Cited by 277
“D1-like receptors can be differentiated from D2-like receptors because of their ability to stimulate adenylyl cyclase activity and increase cyclic adenosine monophosphate (cAMP), which results in an overall excitatory effect within the cell (Kebabian and Calne, 1979).”
BackgroundGerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride
Farde, L., Halldin, C., Stone-Elander, S., & Sedvall, G. (1987) · Psychopharmacology · doi:10.1007/bf00210831 · Cited by 283
Konradi, C., Leveque, J.-C., & Hyman, S. E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-13-04231.1996 · Cited by 283
Dubois, A., Savasta, M., Curet, O., & Scatton, B. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90010-2 · Cited by 279
Neuroendrocrine regulation of prolactin release
BENJONATHAN, N., ARBOGAST, L., & HYDE, J. (1989) · Progress in Neurobiology · doi:10.1016/0301-0082(89)90008-7 · Cited by 278
Mishra, A., Singh, S., & Shukla, S. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518779829 · Cited by 276
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas
DE CAMILLI, P., MACCONI, D., & SPADA, A. (1979) · Nature · doi:10.1038/278252a0 · Cited by 275
Neurobiology of retinal dopamine in relation to degenerative states of the tissue
Djamgoz, M. B. A., Hankins, M. W., Hirano, J., & Archer, S. N. (1997) · Vision Research · doi:10.1016/s0042-6989(97)00129-6 · Cited by 274
Drug and Neurotransmitter Receptors in the Brain
Snyder, S. H. (1984) · Science · doi:10.1126/science.6322304 · Cited by 273
Facilitation of Working Memory in Humans by a D2 Dopamine Receptor Agonist
Luciana, M., Depue, R. A., Arbisi, P., & Leon, A. (1992) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1992.4.1.58 · Cited by 271
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270
Regulation of Akt Signaling by D2and D3Dopamine Receptors In Vivo
Beaulieu, J.-M., Tirotta, E., Sotnikova, T. D., Masri, B., Salahpour, A., Gainetdinov, R. R., Borrelli, E., & Caron, M. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5074-06.2007 · Cited by 269
Martres, M.-P., Bouthenet, M.-L., Sales, N., Sokoloff, P., & Schwartz, J.-C. (1985) · Science · doi:10.1126/science.3838821 · Cited by 267
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Li, P., L. Snyder, G., & E. Vanover, K. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160608084834 · Cited by 266
Calabresi, P., Mercuri, N., Stanzione, P., Stefani, A., & Bernardi, G. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90239-9 · Cited by 262
The role of dopamine in reward and pleasure behaviour – review of data from preclinical research
Bressan, R. A., & Crippa, J. A. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00540.x · Cited by 254
Mechanisms of action of atypical antipsychotic drugs
Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., & Charney, D. S. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90030-u · Cited by 253
Arnt, J., Hyttel, J., & Perregaard, J. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90144-0 · Cited by 253
Chapter 10 Functional roles of dopamine in the vertebrate retina
Witkovsky, P., & Dearry, A. (1991) · Progress in Retinal Research · doi:10.1016/0278-4327(91)90031-v · Cited by 252
All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
Seeman, P. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00162.x · Cited by 228
“Based on these early findings, the target for the antipsychotic drugs was named “the antipsychotic/dopamine receptor” [14], but was later renamed the dopamine D2 receptor [18,19].”
BackgroundStriatal mechanisms underlying movement, reinforcement, and punishment
Kravitz, A. V., & Kreitzer, A. C. (2012) · Physiology · doi:10.1152/physiol.00004.2012 · Cited by 224
Mehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051102 · Cited by 223
“Goldman-Rakic and colleagues have more recently demonstrated that the major class of dopamine D1 receptors, but not the dopamine D2 receptors [see Kebabian and Calne (1979) and Neve and Neve (1997) for explanations of the D1 and D2 receptor families and their respective genetic subtypes; D1 or D5 and D 2 , D 3 or D 4…”
BackgroundNimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Woolverton, W. L. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90553-8 · Cited by 181
Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen
Ouimet, C. C., Langley-Gullion, K. C., & Greengard, P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00724-0 · Cited by 165
Lee, B., Groman, S., London, E. D., & Jentsch, J. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301337 · Cited by 148
Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens
White, N. M., Packard, M. G., & Hiroi, N. (1991) · Psychopharmacology · doi:10.1007/bf02244216 · Cited by 148
Ozaki, S., Narita, M., Narita, M., Iino, M., Sugita, J., Matsumura, Y., & Suzuki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01071.x · Cited by 142
Association of Multiple DRD2 Polymorphisms with Anorexia Nervosa
Bergen, A. W., Yeager, M., Welch, R. A., Haque, K., Ganjei, J. K., van den Bree, M. B. M., Mazzanti, C., Nardi, I., Fichter, M. M., Halmi, K. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300719 · Cited by 137
Hull, E. M., Eaton, R. C., Markowski, V. P., Moses, J., Lumley, L. A., & Loucks, J. A. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90299-5 · Cited by 130
Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1166 · Cited by 123
Receptor subtype-specific dopaminergic agents and conditioned behavior
Beninger, R. J., Hoffman, D. C., & Mazurski, E. J. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80019-3 · Cited by 109
Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300017 · Cited by 105
Excitatory effect of dopamine on oxytocin and vasopressin reflex releases in the rat
Moos, F., & Richard, P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91061-7 · Cited by 104
Huntley, G. W., Morrison, J. H., Prikhozhan, A., & Sealfon, S. C. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90107-m · Cited by 100
Beninger, R. J., Cheng, M., Hahn, B. L., Hoffman, D. C., Mazurski, E. J., Morency, M. A., Ramm, P., & Stewart, R. J. (1987) · Psychopharmacology · doi:10.1007/bf00210842 · Cited by 93
Scigliano, G., & Ronchetti, G. (2013) · CNS Drugs · doi:10.1007/s40263-013-0054-1 · Cited by 92
Nakajima, S., & McKenzie, G. M. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90437-5 · Cited by 81
Ferger, B., Kropf, W., & Kuschinsky, K. (1994) · Psychopharmacology · doi:10.1007/bf02244852 · Cited by 55
D₂ dopamine receptor involvement in the rough-and-tumble play behavior of juvenile rats.
Siviy, S. M., Fleischhauer, A. E., Kerrigan, L. A., & Kuhlman, S. J. (1996) · Behavioral Neuroscience · doi:10.1037/0735-7044.110.5.1168 · Cited by 47
Davidowa, H., Heidel, E., & Plagemann, A. (2002) · Nutritional Neuroscience · doi:10.1080/10284150290007056 · Cited by 21
Pérez de la Mora, M., Borroto-Escuela, D. O., Crespo-Ramírez, M., Rejón-Orantes, J. D. C., Palacios-Lagunas, D. A., Martínez-Mata, M. K., Sánchez-Luna, D., Tesoro-Cruz, E., & Fuxe, K. (2022) · Cells · doi:10.3390/cells11111826 · Cited by 21
Prior acoustic trauma alters type II afferent activity in the mouse cochlea
Nowak, N., Wood, M. B., Glowatzki, E., & Fuchs, P. A. (2021) · eneuro · doi:10.1523/eneuro.0383-21.2021 · Cited by 13
“Two distinctive genes include tyrosine hydroxylase (Th), which encodes the rate-limiting enzyme for the production of dopamine, and Drd2, which encodes a dopamine receptor subunit (Molinoff and Axelrod, 1971; Kebabian and Calne, 1979; Daubner et al., 2011).”
BackgroundDufy, B., & Vincent, J. D. (1980) · Hormones and the Brain · doi:10.1007/978-94-009-8709-8_3 · Cited by 15
Metadata
- Authors
- Kebabian, J. W., & Calne, D. B.
- Venue
- Nature
- Published
- 1979-01-01
- Volume
- 277
- Issue
- 5692
- Pages
- 93-96
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2030905853
- Cited by
- 3,725
- References
- 38
- FWCI
- 77.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.